Status:
COMPLETED
Misoprostol in the Treatment of Postpartum Hemorrhage
Lead Sponsor:
Gynuity Health Projects
Collaborating Sponsors:
Aga Khan University
Aga Khan Health Services
Conditions:
Postpartum Hemorrhage
Eligibility:
FEMALE
Phase:
NA
Brief Summary
Postpartum haemorrhage (PPH) remains a leading cause of maternal mortality, despite treatment with conventional methods. Uncontrolled reports and three small randomised controlled trials have suggeste...
Eligibility Criteria
Inclusion
- All women delivering vaginally with clinically diagnosed PPH requiring uterotonics
Exclusion
- Refusal to give consent for participation or if the woman is too distressed to give consent
- Woman is not entitled to give informed consent (e.g. minors without a guardian)
- Woman who had a caesarean section
- Delivery is regarded as abortion (gestational age \< 28 weeks)
Key Trial Info
Start Date :
December 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2007
Estimated Enrollment :
61 Patients enrolled
Trial Details
Trial ID
NCT00116480
Start Date
December 1 2005
End Date
April 1 2007
Last Update
March 19 2009
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Aga Khan University Hospital
Karachi, Pakistan
2
The Aga Khan Health Services
Karachi, Pakistan